Xstrahl - Model SARRP FLASH -Radiotherapy System for Preclinical Research
The SARRP FLASH system by Xstrahl exemplifies cutting-edge technology in preclinical radiation therapy. This system leverages the advanced FLASH-RT technique, which administers ultra-high dose rates of radiation, significantly surpassing conventional methods. This approach aims to effectively target tumors while minimizing damage to surrounding healthy tissues, making it pivotal for translational cancer research. The system`s adaptability for spatially fractionated radiotherapy and capability for mini and micro-beam collimation enhances its precision in research settings. Designed for use in standard laboratory environments, the SARRP FLASH system offers researchers a robust tool to explore radiobiological responses, contributing to potential new cancer treatment paradigms. Xstrahl also supports educational initiatives to expand the knowledge base of SARRP users, reinforcing its commitment to advancing preclinical radiation research.
Clinical Potential of FLASH
FLASH radiotherapy (FLASH-RT) is a novel, emerging technique whereby tumors are treated with ultra-high dose rates of radiation magnitudes higher than conventional irradiation. Remarkably, this has been shown to reduce damage to normal tissue while still effectively treating diseased areas when compared to conventional therapy. Xstrahl’s photon FLASH irradiator gives investigators the tools to expand preclinical radiation studies using a patented FLASH technique, further supporting translational research into effective cancer treatments.
Adaptable for Spatially Fractionated Radiotherapy
Due to the ultra-high dose rate and narrow penumbra, the SARRP FLASH system is well suited for spatially fractionated research and can be adapted for mini and micro-beam collimation. The SARRP FLASH irradiator marks a milestone with the availability of systems specifically designed for preclinical research that can be used in a standard laboratory environment.